Rachel Weinerman, MD
Schedule an Appointment
First Available: Friday, Mar 6
Biography
- Clinical Assistant Professor
Expertise
- Amenorrhea
- Fertility Preservation
- Gynecology
- In Vitro Fertilization
- Infertility
- Intrauterine Insemination
- Menstrual Cycle Issues
- Minimally Invasive Surgery
- Ovulation Induction
- Polycystic Ovary Syndrome (PCOS)
- Recurrent Pregnancy Loss
- Reproductive Endocrinology and Infertility
- Same-Sex Couples
Awards
2015 Luigi Mastroianni Research Award, Philadelphia Area Reproductive Endocrine Society
2015 Society for Reproductive Endocrinology Prize Paper Award, American Society for Reproductive Medicine Annual Meeting, Baltimore, MD
2014 Research grant from the Foundation for the Assessment and Enhancement of Embryonic Competence
2014 Society of Reproductive Biologists Award for oral presentation at the American Society for Reproductive Medicine Annual Meeting, Honolulu, HI
2013 National Research Service Institutional Training Award (T32), University of Pennsylvania
Office Locations
Patient Satisfaction Reviews
4.7 out of 5
53 Ratings
Board Certifications
- Reproductive Endocrinology/Infertility - American Board of Obstetrics and Gynecology
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Education
Fellowship | Reproductive Endocrinology
Reproductive Endocrinology - University Of Pennsylvania School Of Medicine (2012 - 2015)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - New York University School Of Medicine And Langone Medical Center (2008 - 2012)
Medical Education
Harvard Medical School (2008)
Undergraduate
Harvard University (2003)
Research Interests
In-vitro fertilization perinatal outcomes, Embryo selection, Embryo vitrification
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Rachel Weinerman did not disclose any Outside Relationships with Industry.